Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Metronidazole recalled?

Not under an active recall. Metronidazole was recalled 15 times in the past — all now closed. Most recent: Dec 27, 2022.

Most common reason: Sterility / contamination (8 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Metronidazole. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Metronidazole recalls on record

none so far in 2026; 15 on record, newest first
Class II · Moderate risk

Metronidazole Injection

Lack of Assurance of Sterility: there is potential of a leak from the primary container which may result in a potential breach of sterility and contamination of the product.

Terminated Sterility / contamination Claris Lifesciences Inc NDC 36000-001-24 D-0616-2017
Class II · Moderate risk

Metronidazole Benzoate active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-794-2015
Class II · Moderate risk

Metronidazole Base active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-793-2015
Class II · Moderate risk

Metronidazole Injection USP

Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-1055-48 D-629-2013
Class II · Moderate risk

METRONIDazole Injection

Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7811-24 D-206-2013
Class II · Moderate risk

Metronidazole Tablets

Failed Tablet/Capsule Specifications: Some tablets had the potential to not conform to weight specifications.

Terminated Failed specification Physicians Total Care, Inc. NDC 54868-0158-3 D-547-2013